Improved disease-free survival with osimertinib in EGFR+ lung cancer
Interview and article by Christine Clark. Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado describes the results of the ADAURA trial and the implications for her… read more.